U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula 2CO3.2La.O
Molecular Weight 413.8281
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of Dilanthanum oxydicarbonate

SMILES

[O--].[La+3].[La+3].[O-]C([O-])=O.[O-]C([O-])=O

InChI

InChIKey=NZYPAPJTXHXICO-UHFFFAOYSA-J
InChI=1S/2CH2O3.2La.O/c2*2-1(3)4;;;/h2*(H2,2,3,4);;;/q;;2*+3;-2/p-4

HIDE SMILES / InChI

Molecular Formula La
Molecular Weight 138.9055
Charge 3
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula O
Molecular Weight 15.9994
Charge -2
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula CO3
Molecular Weight 60.0089
Charge -2
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Lanthanum hydroxide (La(OH)3) is a rare novel earth compound which has so far been fabricated with various morphologies such as nanopowders, nanotubes, nanowires, nanorods and nanobelts from different methods like solvothermal, hydrothermal, sol-gel and template assisted routes. This compound has many attractive applications in gas-exhaust convectors, optical coatings, catalysts, superconductors, hydrogen storage materials and next generation of high dielectric constant gate dielectrics. It is a useful carrier precipitate for a number of ions. It was applied to the collection of traces of aluminum, bismuth, gold, iridium, iron, lead, thallium and titanium in silver metal. It is a predecessor Lanthanum oxide, which has a great interest as catalyst material.

Approval Year

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Palliative
FOSRENOL

Approved Use

FOSRENOL is a phosphate binder indicated to reduce serum phosphate in patients with end stage renal disease (ESRD).

Launch Date

2004
PubMed

PubMed

TitleDatePubMed
A confusional state associated with use of lanthanum carbonate in a dialysis patient: a case report.
2009 Oct
Patents
Substance Class Chemical
Created
by admin
on Sat Dec 16 19:14:08 GMT 2023
Edited
by admin
on Sat Dec 16 19:14:08 GMT 2023
Record UNII
T8ZAT24TPR
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
Dilanthanum oxydicarbonate
Common Name English
Lanthanum carbonate oxide (La2(CO3)2O)
Systematic Name English
Dilanthanum dicarbonate oxide
Common Name English
Code System Code Type Description
CAS
77242-85-4
Created by admin on Sat Dec 16 19:14:08 GMT 2023 , Edited by admin on Sat Dec 16 19:14:08 GMT 2023
PRIMARY
PUBCHEM
11509864
Created by admin on Sat Dec 16 19:14:08 GMT 2023 , Edited by admin on Sat Dec 16 19:14:08 GMT 2023
PRIMARY
FDA UNII
T8ZAT24TPR
Created by admin on Sat Dec 16 19:14:08 GMT 2023 , Edited by admin on Sat Dec 16 19:14:08 GMT 2023
PRIMARY